Introduction
Both cancer and diabetes are prevalent diseases whose incidence is increasing globally and have a tremendous impact on health worldwide (1) (2) (3) . Epidemiologic evidence suggests that people with diabetes are at a higher risk of many forms of cancer (including breast, colon, pancreas and etc.) (1) . Moreover, some studies show that patients diagnosed with cancer who have preexisting diabetes are at increased risk for long-term, all-cause mortality compared with those without diabetes (4) . In terms of breast cancer, diabetes was associated with a close to 40% increase in mortality within the first 5 year following breast cancer (5) .
Metastasis of breast cancer is the major cause of tumor-related morbidity and mortality (6, 7) , which involves multistep processes and various cytophysiological changes including altered intercellular interaction between circulating tumor cells and the endothelial cells of blood vessels, and changed adhesion ability between tumor cells and subendothelial extracellular matrix (ECM) (8) . These interactions are considered as important events during tumor metastasis (9) . Multiple and diverse adhesion molecules play a pivotal role in the intercellular and cell-ECM interactions of cancer (10) , such as integrins, the immunoglobulin supergene family, selectins, cadherines and etc (11) . Integrins, which consist of an Į subunit noncovalently linked to a ȕ subunit, are members of a glycoprotein family that forms heterodimeric receptors via which cells attach to ECM, to each other's surfaces or to different cell types (12) . They have been implicated in a wide variety of cellular functions, including cell adhesion, migration, invasion, proliferation and survival (12, 13) . Protein kinase C (PKC) activity has been shown to be important in the regulation of integrins expression, localization (14, 15) and activity (16) . High-density lipoprotein (HDL) contributes importantly to cardiovascular disease risk, with a significant inverse relationship between HDL levels and the risk of cardiovascular disease (17) (18) (19) (20) . Similarly, it has been reported that HDL levels are inversely related to the rates of incident cancer, including breast cancer (21) (22) (23) (24) . However, emerging evidence indicates that HDL can be modified under certain circumstances, such as in diabetes (25) and cardiovascular diseases (26) , and lose its protective effects or even become proatherogenic (25, 27) . HDL isolated from patients with T2DM can be modified into glycated HDL and oxidized HDL (25, 28) and exhibits deficient activities in comparing with normal HDL of healthy subjects (25) . Due to the difference between HDL from healthy subjects and T2DM patients, we speculate that normal and diabetic HDL may have different effects in the metastasis of breast cancer cells and finally lead to the increased mortality of breast cancer in patients with diabetes.
Research. 
Materials and Methods

Patient Characteristics
Written informed consent was obtained from all participants, and the study protocol was approved by the local ethics committee. Each patient volunteer underwent a medical history, physical examination, screening laboratory tests and a 75 g oral glucose tolerance test.
Patients were stable on antihypertensive, hypoglycemic, and lipid-lowering medications.
There was no treatment change during the study. The healthy subjects had no family history of diabetes and had normal glucose tolerance. Characteristics of the study participants are shown in Table 1 . 
Cell Lines and Cell Culture
The hormone-independent MDA-MB-231 and hormone-dependent MCF7 human breast cancer cell lines were from Cell Resource Center, Institute of Basic Medical Sciences, (29) . The cells were plated on gelatin-coated culture dishes in Endothelial Cell Medium (ECM; Sciencell, USA) consisting of 500 ml of basal medium, 25 ml of fetal bovine serum, 5 ml of endothelial cell growth supplement and 5 ml of penicillin/streptomycin solution and then cultured in a humidified incubator at 37 °C with an atmosphere of 5% CO 2 .
HUVEC were used at passages 2-5.
Isolation, Glycation and oxidation of HDL
Fresh, fasting plasma was separated by centrifugation from peripheral blood obtained from healthy subjects (n=102) and type 2 diabetic patients (n=107). LDL (1.019-1.063) and HDL (1.063-1.210) were isolated from fresh plasma by ultracentrifugation as previously described (30) . HDL from each individual were dialyzed against 3×1 L of endotoxin-free PBS (pH=7. 4) and 100 μM diethylenetriamine pentaacetic acid (DTPA) (Sigma, USA), sterilized with 0.22 μm filter, stored in sealed tubes at 4 °C in dark and used within 2 months. To create glycated HDL, fresh human HDL (5 mg protein) was incubated with 25 mmol/L glucose in PBS under sterile conditions for 1 week at 37 °C (referred to as G-HDL) (31) . Glycation of the apoA-I components of HDL was measured using mass spectrometry. Oxidative modi¿cation of HDL was performed by dialysis at lipoprotein concentration of 0.8 mg protein/mL against PBS containing 5 μM CuSO4 for 24 hours at 37 °C (referred to as Ox-HDL) (32) 
Histology
Tissues were fixed in buffered formalin for 24-48h. After washing in fresh PBS, fixed tissues were processed and embedded in paraffin. Sections (5 milli micron) were collected on microscope slides, deparaffinized and stained with H&E. The images were captured at 10x magnification.
TC-HUVEC Adhesion Assay
TC-HUVEC adhesion was measured using rose Bengal stain as previously described method (33 
TC-ECM Adhesion Assay
Cell adhesion was measured using MTT assay as previously described method (34) . Briefly, 96-well flat bottom plates were coated with 2 μg/well basement membrane matrix (Matrigel, BD, Germany) for a hour at 37 °C then blocked with 2% BSA for 2 hours at 37 °C followed by washing twice. Tumor cells seeded on 12-well plate were treated with serum-free DMEM alone or HDL (normal, diabetic, glycated or oxidized) for 6 hours. After detachment with trypsin, the cells (1×10 
Determination of Cell Surface Expression of Adhesion Molecules by Enzyme
Immunoassay
Cells in 96-well plates were grown till 70% confluency, then treated with HDL (normal, diabetic, glycated or oxidized) in serum-free medium for 6 hours at 37 . Cells were washed with PBS and fixed with methanol for 5 minutes and then washed with PBS 3 times and blocked with 2% BSA for 2 hours at 37 °C. Cell surface expression of adhesion molecules were determined by primary binding with specific monoclonal antibodies for integrin ȕ1, integrin ȕ2, integrin ȕ3, integrin Įv (1:200; Abcam, Hong Kong) followed by secondary binding with a horseradish peroxidase-conjugated antibody (1:3000; Boster, China) as described previously (35) . Quantification was performed by determination of colorimetric conversion at an optical density at 450 nm of 3,3,5,5-tetramethylbenzidine using TMB peroxidase EIA substrate kit (Bio-Med innovation, China).
PepTag Assay for Nonradioactive Detection of PKC Activity
The PKC activity in the MDA-MB-231 and MCF7 cell lysates was determined by non-radioactive detection kit of protein kinase (PepTag Corporation, USA), following the manufacturer's instructions. Briefly, PKC in the HDL-treated cell lysates was separated by column of DEAE cellulose and was incubated with the brightly colored, fluorescent peptide substrates. Then phosphorylation by PKC of its specific substrate alters the peptide's net charge from +1 to -1, which allows the phosphorylated and non-phosphorylated versions of the substrate to be rapidly separated on an agarose gel. 
Results
Participants
Baseline demographic and clinical characteristics of healthy subjects and patients with type 2 diabetes mellitus are shown in Table 1 Consistent results were obtained in the hematoxylin and eosin stained sections ( Figure 1E ).
Weight of mice during the study was shown (Supplement Figure 1A , B). 
higher respectively in the TC-HUVEC adhesion assay ( Figure 2C) , and the attachment of MDA-MB-231 and MCF7 cells induced by diabetic HDL was 27.6% (P<0.01) and 23.5% (P<0.05) higher respectively in the TC-ECM adhesion assay ( Figure 2D ). Integrins have been reported to play a key role in TC-HUVEC and TC-ECM adhesion.
Anti
Diabetic, glycated and oxidized HDL induced elevated expressions of integrin ȕ1 ( Figure 4A ), integrin ȕ2 ( Figure 4B ), integrin ȕ3 ( Figure 4C ) and integrin Įv ( Figure 4D) Figure 4E ).
Diabetic, glycated and oxidized HDL-induced MDA-MB-231 and MCF7 cell metastasis involves PKC pathway.
It is reported that PKC activity is associated with the regulation of integrin-related adhesion.
Therefore, PKC activity induced by normal, diabetic, glycated and oxidized HDL was Figure 5D ).
Discussion
Previous study suggests complex associations between T2DM and breast cancer (37) .
Diabetes may have direct biologic effects on breast cancer risk, clinical and pathological characteristics and outcome. Moreover, certain antidiabetic therapies may have direct activity against breast cancer. Diabetes may also affect breast cancer outcome indirectly, and has been shown to influence medical decision-making regarding screening and management of breast cancer (37) . In addition, some studies pointed that it is possible that cancer is well-known to be a pro-inflammatory state while the decreased level of HDL is inefficient to exert its anti-inflammatory effects, which allows tumor cell proliferation, survival and migration (38, 39) . Our study provides a novel view and demonstrates the significant difference between diabetic and normal HDL on breast cancer cell metastasis progression.
We previously found that HDL in type 2 diabetes mellitus can be glycated and oxidized, and diabetic HDL was found to promote proliferation, migration and invasion of breast cancer cells in vitro as compared with normal HDL (36) . Glycated and oxidized HDL produced in vitro were used to partly mimic diabetic HDL. Diabetic, glycated and oxidized HDL could induce higher synthesis and secretion of VEGF-C, MMP-2 and MMP-9 from MDA-MB-231 cells (36) . It was indicated that diabetic, glycated and oxidized HDL promote MDA-MB-231 cell migration and invasion through ERK and p38 MAPK pathways, and Akt pathway plays an important role as well in MDA-MB-231 cell invasion (36) . It drove us to speculate that diabetic HDL may have elevated ability of promoting breast cancer cell metastasis.
In our present study, we have demonstrated that diabetic, glycated and oxidized HDL, which were compared with normal HDL, could promote breast cancer cells metastasis in vivo 
and cell adhesion to HUVEC and ECM in vitro in similar ways, and could induce much higher expression of integrins on the cell surface, and increase the activity of PKC as well.
Moreover, we observed that staurosporine, a PKC inhibitor, inhibited breast cancer cell adhesion to HUVEC and ECM which were induced by diabetic, glycated and oxidized HDL, as well as the expression of integrins. The present data demonstrated that the increased capabilities of diabetic, glycated, and oxidized HDL in promoting breast cancer cell adhesion to HUVEC and ECM is mainly due to the elevated PKC activity. The activated PKC could in turn stimulate secretions of integrin ȕ1, integrin ȕ2, integrin ȕ3 and integrin ĮȞ, which are of vital importance in promoting breast cancer cell metastasis. Our study used a tail-vein injection model to investigate the effects of normal, diabetic, glycated and oxidized HDL on breast cancer cell metastasis in vivo. A spontaneous metastatic model can be further employed to study the effects of different forms of HDL on breast cancer development in nude mice, including tumor growth and metastasis (40) . In addition, fluorescence imaging techniques can be applied to visualize the interaction of breast cancer cells with vasculature and ECM in nude mice, including tumor cell mobility, invasion, metastasis and angiogenesis (41, 42) . All the studies were performed on both hormone-independent (MDA-MB-231) and hormone-dependent (MCF7) cell lines. We found that MDA-MB-231 cells presented to have (43) . However, our study observed similar effects of diabetic, glycated and oxidized HDL on the cell adhesion to HUVEC and to ECM between hormone-independent (MDA-MB-231) cells and hormone-dependent (MCF7) cells compared with normal HDL.
HDL plays an extremely important role of protecting the cardiovascular system from atherosclerosis, including reversing cholesterol transport (RCT), anti-inflammatory, anti-oxidant properties, anti-thrombotic and etc. For instance, HDL can mediate reverse cholesterol transport through its receptors of SR-BI and ABCAI (44) . Also, HDL is potential carriers of enzymatic proteins, such as paraoxonase and platelet-activating factor (PAF)-acetyl hydrolase, which can hydrolyze phospholipid peroxides and cholesteryl ester peroxides (44) .
In addition, HDL may inhibit adhesion molecule expression through SR-BI and S1P receptors (especially S1P-1) when an inflammatory cytokine such as TNF-Į is a pro-atherogenic stimulant (45) . Furthermore, a recent study found that HDL can mediate signal transduction of extracellular signal-regulated kinase (ERK) 1/2 and Akt by an ABCA1-dependent mechanism, leading to increased proliferation and migration of prostate cancer cells (46) . (48) . In our present study, we found glycated and oxidized HDL, as well as diabetic HDL have increased capability of promoting breast cancer metastasis through upregulating the PKC pathway related integrins expression. All the experimental evidence allows us to speculate that the promoting effects of diabetic HDL on breast cancer cell metastasis, at least partially, may be attributed to the glycation and oxidation of HDL. Owing to the complicated composition of HDL, it needs further intensive research to determine the altered parts of HDL (both in quality and in quantity) in diabetic patients and how they act in different ways to advance breast cancer development.
Evidence from epidemiologic studies also demonstrates that some pathologic alterations including changes of lipids profile levels (22, 49) in T2DM could raise higher risk of breast cancer (43) . Notably, low level of HDL, frequently presented in the patients with T2DM and metabolic syndrome, is strongly linked with breast cancer (49, 50) . Our study here provided supporting biological evidence (Supplement Figure 2A All the evidence substantially supported the concept that T2DM is closely related to breast cancer, which could at least be partially attributed to the alterations of HDL in T2DM, not only to the declined quantity but also to the altered structures and compositions. Our study demonstrates that the modifications of HDL in the diabetic patients could lead to accelerated breast cancer metastasis progression. This will bring more attention on the therapeutic strategies based on HDL function, especially in the patients of diabetes with breast cancer. Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
Values are expressed as mean ± SD.
